Inhibition of xenograft tumor growth in mice by gold nanoparticle-assisted delivery of short hairpin RNAs against Mcl-1L
► We show that a functionalized gold nanoparticle can deliver shRNAs in a mouse model. ► We show that delivery of shRNAs targeted to Mcl-1L gene leads to antitumor activity. ► Our “lego-like” system can load and deliver any sequences of RNA into living systems. A prerequisite for the therapeutic use...
Gespeichert in:
Veröffentlicht in: | Journal of biotechnology 2011-11, Vol.156 (2), p.89-94 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ► We show that a functionalized gold nanoparticle can deliver shRNAs in a mouse model. ► We show that delivery of shRNAs targeted to Mcl-1L gene leads to antitumor activity. ► Our “lego-like” system can load and deliver any sequences of RNA into living systems.
A prerequisite for the therapeutic use of small RNAs is the development of a method that can deliver them into animals. Previous studies have shown the capability of functionalized gold nanoparticles to serve as a general platform for loading and delivering DNA oligonucleotides and short hairpin RNAs (shRNAs) into cultured human cells. Here, we report the ability of the gold nanoparticle-assisted gene delivery system (AuNP-GDS) to deliver shRNA to a xenograft tumor in a mouse model. AuNP-GDS delivery of
in vitro synthesized shRNA targeted to the Mcl-1L gene knocked down levels of Mcl-1L mRNA and protein by ∼36% and ∼26%, respectively, which were sufficient to induce apoptosis of the xenograft tumor cells and consequently inhibited the development of the tumor. We demonstrated that our lego-like AuNP-GDS, which can easily load and deliver shRNAs targeted to any gene of interest into living systems, can deliver shRNAs into xenograft tumors, leading to antitumor activity in an animal model. |
---|---|
ISSN: | 0168-1656 1873-4863 |
DOI: | 10.1016/j.jbiotec.2011.07.037 |